This is the authors' abstract. We don't add key points for this paper.
Independent lines of evidence implicate the amygdala in the pathophysiology of mental illness or substance use disorders. In order to elucidate the role of the amygdala in these disorders in a neurodevelopmental context, and as comorbid conditions, we tested the effects of neonatal amygdala lesions (NAL) in rats in mental illness and addiction‐related paradigms. Adult NAL rats show altered responses to social and anxiogenic stimuli, and they are hyperresponsive to both novelty and repeated cocaine injections. Additionally, drug history has differential behavioral effects on NAL and non‐lesioned animals. Taken together, these results suggest that the amygdala is an important neurocircuit component underlying substance disorder comorbidity in mental illness, and that NALs may represent a viable animal model of dual‐diagnosis phenomena. Support provided by Indiana University Office of the Vice Chancellor for Collaborative Research Programs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lafuze et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: